Skip to content

Insider · CIK 0001708269

Atlas Venture Fund XI, L.P.

owner

Files at THRD (Third Harmonic Bio, Inc.), SION (Sionna Therapeutics, Inc.). First filing Feb 10, 2025, latest Feb 10, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$1.1M bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

SION: Sionna Therapeutics, Inc.

SIONOct 9, 2026 · close 4.90

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
50Moderate
SIONbuy 4
Sionna Therapeutics, Inc.
$1.1M
60,000 shares
+8%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 10, 2025SION
Sionna Therapeutics, Inc.
CConversion
Common Stock
+2,886,293--2,886,293Feb 10, 2025
Feb 10, 2025SION
Sionna Therapeutics, Inc.
CConversion
Common Stockindirect: By Atlas Venture Opportunity Fund II, L.P.
+747,727--747,727Feb 10, 2025
Feb 10, 2025SION
Sionna Therapeutics, Inc.
POpen-market purchase
Common Stockindirect: By Atlas Venture Opportunity Fund II, L.P.
+60,000$18.00$1.1M807,727Feb 10, 2025
Feb 10, 2025SION
Sionna Therapeutics, Inc.
CConversion
Series Seed convertible preferred stockderivative
-1,051,051$0.00$00Feb 10, 2025
Feb 10, 2025SION
Sionna Therapeutics, Inc.
CConversion
Series A convertible preferred stockderivative
-1,806,317$0.00$00Feb 10, 2025
Feb 10, 2025SION
Sionna Therapeutics, Inc.
CConversion
Series B convertible preferred stockderivative
-1,298,332$0.00$00Feb 10, 2025
Feb 10, 2025SION
Sionna Therapeutics, Inc.
CConversion
Series C convertible preferred stockderivative
-61,463$0.00$00Feb 10, 2025
Feb 10, 2025SION
Sionna Therapeutics, Inc.
CConversion
Series C convertible preferred stockderivativeindirect: By Atlas Venture Opportunity Fund II, L.P.
-1,092,504$0.00$00Feb 10, 2025
Nov 1, 2024THRD
Third Harmonic Bio, Inc.
JOther
Common Stock10b5-1
-515,688$0.00$09,798,075Nov 5, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Atlas Venture Fund XI, L.P.: insider trades and track record | InsiderTell